glp-1 new hope agonists for opioid use disorder: a hope? | Brittany Albright MD, MPH, DABOM posted on the topic GLP-1 - Industry Knowledge -
Description
While traditional smoking cessation methods have shown some success, many still struggle to quit
Background Regular exercise is an effective non-pharmacological therapy for treatment and prevention of cardiovascular diseases (CVD)
The drug does something to Alzheimer's biology - the question is when to use it.
Physician-managed GLP-1 in Scarsdale NY: semaglutide $499/mo, tirzepatide $799/mo, STYKU 3D body composition tracking
It met the applicable Clean Label Project certification requirements
